Prevalence and significance of Mycoplasma genitalium in women living with HIV in Denmark

Autor: Anne Marie Rosendahl Madsen, Kristina Thorsteinsson, Anne-Mette Lebech, Merete Storgaard, Terese L. Katzenstein, Frederikke F. Rönsholt, Isik Somuncu Johansen, Gitte Pedersen, Lars Noerregaard Nielsen, Aase Bengaard Andersen, Jørgen Skov Jensen

Publikováno v: BMC Research Notes, Vol 10, Iss 1, Pp 1-5 (2017)

Abstract Objective Mycoplasma genitalium (M. genitalium) is a sexually transmitted pathogen associated with urethritis, cervicitis, and pelvic inflammatory disease. Previous studies have shown a strong association between M. genitalium and HIV infect

Externí odkaz: https://doaj.org/article/124b10b5b08748f284ce0274d815f5c1

Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark

Autor: Maria Wessman, Kristina Thorsteinsson, Jørgen S. Jensen, Merete Storgaard, Frederikke F. Rönsholt, Isik S. Johansen, Gitte Pedersen, Lars Nørregård Nielsen, Jesper Bonde, Terese L. Katzenstein, Nina Weis, Anne-Mette Lebech

Publikováno v: BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-10 (2017)

Abstract Background Bacterial vaginosis (BV) has been found to be associated with HIV acquisition and transmission. This is suggested to be due to higher HIV RNA levels in cervicovaginal fluids in women living with HIV (WLWH) with BV, as bacteria ass

Externí odkaz: https://doaj.org/article/727fa328edb74fe48f298bd21888b211

Olfactory and Gustatory Outcomes Including Health-Related Quality of Life 3–6 and 12 Months after Severe-to-Critical COVID-19: A SECURe Prospective Cohort Study

Autor: Elisabeth Arndal, Anne-Mette Lebech, Daria Podlekarava, Jann Mortensen, Jan Christensen, Frederikke F. Rönsholt, Thomas Kromann Lund, Terese L. Katzenstein, Christian von Buchwald

Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 20; Pages: 6025
Arndal, E, Lebech, A M, Podlekarava, D, Mortensen, J, Christensen, J, Rönsholt, F F, Lund, T K, Katzenstein, T L & von Buchwald, C 2022, ' Olfactory and Gustatory Outcomes Including Health-Related Quality of Life 3–6 and 12 Months after Severe-to-Critical COVID-19 : A SECURe Prospective Cohort Study ', Journal of Clinical Medicine, vol. 11, no. 20, 6025 . https://doi.org/10.3390/jcm11206025

Background: Long-term follow-up studies of COVID-19 olfactory and gustatory disorders (OGDs) are scarce. OGD, parosmia, and dysgeusia affect health-related quality of life (HRQoL) and the ability to detect potential hazards. Methods: In this study, 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d25c810006fb8db66cbb754c590f3f1

Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy.

Autor: Frederikke F Rönsholt, Henrik Ullum, Terese L Katzenstein, Jan Gerstoft, Sisse R Ostrowski

Publikováno v: PLoS ONE, Vol 8, Iss 6, p e65182 (2013)

The study investigated markers of inflammation and endothelial activation in HIV infected patients after 12 years of successful combination antiretroviral treatment (cART).Inflammation and endothelial activation were assessed by measuring levels of i

Externí odkaz: https://doaj.org/article/01ee2321f40440539d3f1546aa072d15

Close monitoring and early intervention: management principles for cystic fibrosis in Denmark.

Autor: Qvist T; Cystic Fibrosis Center Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Nielsen BU; Cystic Fibrosis Center Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Olesen HV; Cystic Fibrosis Center Aarhus, Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Mathiesen IHM; Cystic Fibrosis Center Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Faurholt-Jepsen D; Cystic Fibrosis Center Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Katzenstein TL; Cystic Fibrosis Center Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Helweg-Larsen J; Cystic Fibrosis Center Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Rönsholt F; Department of Cardiology, Section for Lung Transplantation, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Jeppesen M; Cystic Fibrosis Center Aarhus, Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark., Olsen MF; Cystic Fibrosis Center Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Buchvald FF; Cystic Fibrosis Center Copenhagen, Danish Pediatric Pulmonary Service, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Nielsen KG; Cystic Fibrosis Center Copenhagen, Danish Pediatric Pulmonary Service, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Jensen-Fangel S; Cystic Fibrosis Center Aarhus, Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark., Pressler T; Cystic Fibrosis Center Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Cystic Fibrosis Center Copenhagen, Danish Pediatric Pulmonary Service, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Skov M; Cystic Fibrosis Center Copenhagen, Danish Pediatric Pulmonary Service, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Publikováno v: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2024 Apr; Vol. 132 (4), pp. 223-235. Date of Electronic Publication: 2024 Jan 24.